AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong demand for its cancer and rare diseases medicines, after third-quarter results beat estimates.
Spotify's Q3 Profit Quadruples
Home Depot reported decent revenue growth for Q3 thanks, in part, to hurricane activity, but it experienced a decline in net ...
Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...
AstraZeneca's Q3 sales rose 18% YoY to $13.6 billion Adjusted EPADS hit $1.04, exceeding expectations. U.S. investment of ...
Shopify reported robust quarterly earnings, beating expectations, driven by strong segment growth and cost management.
Hosted on MSN21h
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat(Reuters) - Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on ...
Nvidia Corporation's AI-driven growth continues, but a cyclical decline looms when the first infrastructure build-out peaks.
Shopify reported 26% revenue growth in Q3, reaching $2.16 billion, beating estimates and marking its sixth consecutive ...
IAC CEO Joey Levin, in an internal company memo about the Q3 earnings, wrote, "Even little Daily Beast had a great quarter, ...
EVgo Inc (NASDAQ:EVGO) shares are trading higher after the company reported third-quarter sales growth of 92% year-on-year to ...
Sea Limited beat expectations in Q3, showcasing notable growth on top and bottom lines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback